protalix management:Protalix BioTherapeutics Inc

Protalix BioTherapeutics Inc

Protalix BioTherapeutics Inc

ThefollowingsectionprovidesinformationonProtalixBioTherapeuticsInc'sseniormanagement,executives,CEOandkeydecisionmakersandtheirrolesinthe ...。其他文章還包含有:「Aboutus」、「ProtalixBioTherapeutics」、「Protalix」、「ProtalixBioTherapeutics」、「Contacts」、「ProtalixBiotherapeutics」、「ProtalixBioTherapeuticstoAnnounceSecondQuarter...」、「ProtalixBioTherapeuticstoAnnounceFirstQuarter2024....

查看更多 離開網站

Provide From Google
About us
About us

https://protalix.com

Management · Dror Bashan. Mr. Bashan has served as our President and Chief Executive Officer and as our director since June 2019. · Eyal Rubin. Mr. Rubin has ...

Provide From Google
Protalix BioTherapeutics
Protalix BioTherapeutics

http://ir.protalix.com

Protalix is a biopharmaceutical company focused on the development, production, and commercialization of innovative medicines for patients living with rare ...

Provide From Google
Protalix
Protalix

https://protalix.com

Protalix is dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with our ProCellEx ...

Provide From Google
Protalix BioTherapeutics
Protalix BioTherapeutics

https://simplywall.st

Management criteria checks 3/4 ... Protalix BioTherapeutics' CEO is Dror Bashan, appointed in Jun 2019, has a tenure of 5.08 years. total yearly compensation is ...

Provide From Google
Contacts
Contacts

https://protalixbiotherapeutic

Management · Board of Directors · Scientific Advisory Board · Environmental ... [email protected]. Other information: [email protected]. Shareholder Tools. Print ...

Provide From Google
Protalix Biotherapeutics
Protalix Biotherapeutics

https://tw.linkedin.com

Protalix (NYSE American, TASE: PLX) is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins ...

Provide From Google
Protalix BioTherapeutics to Announce Second Quarter ...
Protalix BioTherapeutics to Announce Second Quarter ...

https://www.prnewswire.com

Management will host a conference call with investors to discuss the financial results and provide an update on recent corporate and ...

Provide From Google
Protalix BioTherapeutics to Announce First Quarter 2024 ...
Protalix BioTherapeutics to Announce First Quarter 2024 ...

https://protalixbiotherapeutic

Management will host a conference call with investors to discuss the financial results and provide an update on recent corporate and regulatory developments.

Provide From Google
ProCellEx®Platform
ProCellEx®Platform

https://protalix.com

ProCellEx® is our proprietary platform used to produce and manufacture recombinant proteins through plant cell-based expression systems.